Keystone Investors Pte LTD Charles River Laboratories International, Inc. Transaction History
Keystone Investors Pte LTD
- $1.17 Billion
- Q2 2024
A detailed history of Keystone Investors Pte LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Keystone Investors Pte LTD holds 106,278 shares of CRL stock, worth $20.3 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
106,278
Previous 123,617
14.03%
Holding current value
$20.3 Million
Previous $33.5 Million
34.45%
% of portfolio
1.88%
Previous 2.93%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
730Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$971 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$399 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$364 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$261 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...